These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 22246327

  • 1. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 2. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 3. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.
    Med Oncol; 2014 Feb 01; 31(2):784. PubMed ID: 24366688
    [Abstract] [Full Text] [Related]

  • 4. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M.
    Ann Oncol; 2009 Jul 01; 20(7):1216-22. PubMed ID: 19164452
    [Abstract] [Full Text] [Related]

  • 5. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM.
    Dig Dis Sci; 2011 Oct 01; 56(10):2992-3004. PubMed ID: 21674174
    [Abstract] [Full Text] [Related]

  • 6. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
    Su Y, Xu H, Xu Y, Yu J, Xian Y, Luo Q.
    Hematology; 2012 Jan 01; 17(1):41-6. PubMed ID: 22549447
    [Abstract] [Full Text] [Related]

  • 7. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S, Jordanov SH, Mitkova AV, Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP, Goranova TE.
    Head Neck; 2014 Aug 01; 36(8):1103-8. PubMed ID: 23804521
    [Abstract] [Full Text] [Related]

  • 8. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells].
    Meng CF, Zhu XJ, Dai DQ, Peng G.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep 01; 12(5):494-7. PubMed ID: 19742343
    [Abstract] [Full Text] [Related]

  • 9. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J, Pongsapich W, Mann SA, Hedrich J, Fruth K, Pogozelski B, Mann WJ.
    Oral Oncol; 2010 Sep 01; 46(9):678-83. PubMed ID: 20729134
    [Abstract] [Full Text] [Related]

  • 10. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
    Alvarez MC, Santos JC, Maniezzo N, Ladeira MS, da Silva AL, Scaletsky IC, Pedrazzoli J, Ribeiro ML.
    World J Gastroenterol; 2013 May 28; 19(20):3043-51. PubMed ID: 23716983
    [Abstract] [Full Text] [Related]

  • 11. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH.
    Langenbecks Arch Surg; 2011 Oct 28; 396(7):1017-26. PubMed ID: 21706233
    [Abstract] [Full Text] [Related]

  • 12. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY, He QY, Guo MZ.
    World J Gastroenterol; 2012 Jun 14; 18(22):2844-9. PubMed ID: 22719195
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic inactivation of RASSF1A in head and neck cancer.
    Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3635-40. PubMed ID: 14506151
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.
    Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217
    [Abstract] [Full Text] [Related]

  • 15. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 01; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 16. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 01; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

  • 17. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 18. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.
    Int J Oncol; 2008 Sep 01; 33(3):469-75. PubMed ID: 18695875
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells.
    Brieger J, Mann SA, Pongsapich W, Koutsimpelas D, Fruth K, Mann WJ.
    Int J Mol Med; 2012 Mar 01; 29(3):505-9. PubMed ID: 22109647
    [Abstract] [Full Text] [Related]

  • 20. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F.
    Eur J Cancer; 2002 Aug 01; 38(12):1585-92. PubMed ID: 12142046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.